Will MDR-1/P-gp modulators provide clinical benefit in hematologic malignancies? [electronic resource]
Producer: 20060912Description: 1077-8 p. digitalISSN:- 0145-2126
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- antagonists & inhibitors
- Animals
- Antibiotics, Antineoplastic -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Blast Crisis -- drug therapy
- Carbazoles -- pharmacology
- Cell Line, Tumor
- Daunorubicin -- pharmacology
- Drug Resistance, Neoplasm -- drug effects
- Drug Screening Assays, Antitumor
- Enzyme Inhibitors -- pharmacology
- Humans
- Indoles -- pharmacology
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Mice
- Mice, Inbred BALB C
- Mice, Transgenic
- Multiple Myeloma -- drug therapy
- Pyrroles -- pharmacology
No physical items for this record
Publication Type: Editorial; Comment
There are no comments on this title.
Log in to your account to post a comment.